BETTERLIFE PHARMA INC.: 10-K filed 2015-05-15
What BETTERLIFE PHARMA INC. reported in its annual report filed 2015-05-15 (fiscal FY 2015): 21 published measures, 44 facts as tagged in accession 0001477932-15-003314.
This filing
- Form
- 10-K (annual report)
- Filed
- 2015-05-15
- Fiscal period
- fiscal FY 2015
- Accession
- 0001477932-15-003314 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BETTERLIFE PHARMA INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-01-31 | 1,610 | CAD | |
| At 2014-01-31 | 7,167 | CAD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-01-31 | 71,053 | CAD | |
| At 2014-01-31 | 757,680 | CAD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-01-31 | -69,443 | CAD | |
| At 2014-01-31 | -750,513 | CAD | |
| At 2013-01-31 | -674,638 | CAD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-01-31 | 1,067 | CAD | |
| At 2014-01-31 | 1,044 | CAD | |
| At 2013-01-31 | 475 | CAD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-02-01 to 2015-01-31 | -1,002,532 | CAD | 365 |
| 2013-02-01 to 2014-01-31 | -753,875 | CAD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-02-01 to 2015-01-31 | -52,664 | CAD | 365 |
| 2013-02-01 to 2014-01-31 | -27,276 | CAD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-02-01 to 2015-01-31 | 52,688 | CAD | 365 |
| 2013-02-01 to 2014-01-31 | 27,845 | CAD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-01-31 | -3,916,779 | CAD | |
| At 2014-01-31 | -2,914,247 | CAD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-02-01 to 2015-01-31 | 11,599,995 | shares | 365 |
| 2013-02-01 to 2014-01-31 | 4,828,702 | shares | 365 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-02-01 to 2015-01-31 | -0.09 | CAD/shares | 365 |
| 2013-02-01 to 2014-01-31 | -0.2 | CAD/shares | 365 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-02-01 to 2015-01-31 | -0.09 | CAD/shares | 365 |
| 2013-02-01 to 2014-01-31 | -0.2 | CAD/shares | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-01-31 | 417 | CAD | |
| At 2014-01-31 | 872 | CAD |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-01-31 | 1,193 | CAD | |
| At 2014-01-31 | 6,295 | CAD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-02-01 to 2015-01-31 | 72,247 | CAD | 365 |
| 2013-02-01 to 2014-01-31 | 35,131 | CAD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-01-31 | 71,053 | CAD | |
| At 2014-01-31 | 728,915 | CAD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-01-31 | 126 | CAD | |
| At 2014-01-31 | 5,251 | CAD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-02-01 to 2015-01-31 | 130,810 | CAD | 365 |
| 2013-02-01 to 2014-01-31 | 76,887 | CAD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-01-31 | 65,863,766 | shares | |
| At 2014-01-31 | 10,076,707 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-01-31 | 3,871,470 | CAD | |
| At 2014-01-31 | 1,928,657 | CAD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-02-01 to 2015-01-31 | 34,080 | CAD | 365 |
| 2013-02-01 to 2014-01-31 | 25,436 | CAD | 365 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-02-01 to 2015-01-31 | 455 | CAD | 365 |
| 2013-02-01 to 2014-01-31 | 455 | CAD | 365 |
Inspect the source
- Entity
- BETTERLIFE PHARMA INC. / CIK 0001464165
- Captured
- 2026-09-20T09:06:34.124Z
- SEC response SHA-256
da89258f023cbc29ad1ecdd31014873fa96a7739fba3e7b66a8b80f8715d36cf
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001464165.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))